A team of Dana-Farber researchers has identified a potential new way to assess clinically valuable features of clear cell renal cell carcinoma (ccRCC; pictured) using image processing with deep learning.
The Innovative Devices Access Pathway (IDAP) pilot has been launched, supported by £10 million of Government funding, with the aim of expediting UK patient access to innovative technologies by providing innovators and manufacturers with multi-partner support and targeted scientific advice.
The British Journal of Biomedical Science is excited to announce a new award for biomedical Scientists at the start of their research career. The BJBS Publishing Prize aims to inspire biomedical scientists at the start of their research careers to submit their research to the journal.
Imaging firm Evident has announced an alliance with Corista, Sakura Finetek USA and Visiopharm to deliver an automated, end-to-end workflow solution for pathology in the USA. Together, the scientific leaders will combine their technologies to streamline the workflow of staining, imaging, and analysing whole slide images with the collaboration and management needed in today’s high-volume laboratories.
HORIBA UK has expanded its clinical chemistry portfolio with the addition of a new test kit for glucose-6-phosphate dehydrogenase (G6PD) from Pointe Scientific. Used for the quantitative determination of G6PD enzyme activity in blood, the CE-marked POINTE G6PD assay kit combines everything required for undertaking G6PD testing, excluding controls, in a single box.
The new BOND-PRIME Advanced Staining Solution from Leica Biosystems has its first event unveiling at this year’s IBMS Congress (stand 608). BOND-PRIME is a faster, more advanced staining solution, featuring all elements of Universal Access – able to handle any slide, in any combination, at any time, using any reagent.
AI-powered pathology solutions provider Aiosyn has announced the release of an AI kidney suite designed to advance research in the field of renal disease. Leveraging cutting-edge deep learning technology, this solution provides biopharma and research organisations with powerful tools for analysing kidney structures and quantifying lesions that impact kidney health.
US-based laboratory Navigate BioPharma Services has announced a strategic collaboration with medical technology company BD (Becton, Dickinson and Company) to develop and commercialise flow cytometry-based companion diagnostics and tools for clinical decisions.
Agilent Technologies and Exact Sciences Corp, a leading provider of cancer screening and diagnostic tests, have announced they have entered into a definitive agreement for the sale of Resolution Bioscience to Exact Sciences.
A new independent report released by UKRI underscores the pivotal role played by UK researchers and innovators in tackling the pandemic.
The European Laboratory Research & Innovation Group (ELRIG) UK has announced the formation of its Engagement Strategy Work Group (ESWG). The group will provide strategic direction and guidance to help ensure the ELRIG community continues to grow and thrive.
Dell Technologies has joined forces with the University of Limerick's Digital Cancer Research Centre to develop an artificial intelligence (AI) platform and digital twin technology to power predictive and diagnostic research in oncology.
The Medical Research Council (MRC) has announced a new £2 million investment supporting researchers to understand and treat cancers with exceptionally poor survival rates, including of the brain, lung and oesophagus. Four research innovation teams will each receive £500,000 to work across disciplines on high-risk, high-reward projects towards improving outcomes of hard-to-treat cancers.
Randox offers an extensive product offering comprising third-party quality controls and calibrators, interlaboratory data management, external quality assessment, calibration verification and molecular IQC and EQA for infectious disease testing. Randox Quality Control is now set to add eight Quality Controls to its range.
HORIBA UK will be marking its 70th anniversary at IBMS Congress later this month, where delegates are invited to join the celebrations and also to see the company’s newly launched fully automated haemostasis analysers.